Discount and CAL: How much capital really gets released, when, and what it does to ROE
Discount is set to receive NIS 2.694 billion in cash when the CAL sale closes, but another NIS 180 million depends on CAL's 2027 and 2028 performance, and the immediate gain estimated at NIS 370 million after tax erodes as closing slips. The regulatory capital release is real, yet in the near term the bank itself warns of temporary ROE dilution until that surplus capital is either redeployed or distributed.
What This Follow-up Is Isolating
The main article already argued that Discount's core banking engine looks better than the headline, but that 2026 is still a proof year as long as the CAL sale remains unresolved. This continuation isolates only the capital layer: how much actually gets released, when it gets released, and what that means for ROE.
The first non-obvious point is that the biggest headline number is not the amount available on day one. The headline is up to NIS 2.873 billion, but the immediate component due at closing is about NIS 2.694 billion. Another amount of up to NIS 180 million depends on CAL's business performance in 2027 and 2028. Part of the value, then, is not day-one deployable capital at all. It is later and contingent.
The second point is that accounting gain and cash are not the same thing. In December 31, 2025 terms, Discount estimated an after-tax gain of about NIS 370 million at closing, plus a possible future after-tax gain of up to about NIS 125 million if the contingent consideration is earned. But the bank also says explicitly that until closing it will keep recognizing its share of CAL's profits, which raises CAL's carrying value on the balance sheet and reduces the sale-gain estimate.
That creates the core paradox. The deal is clearly capital-accretive, but not automatically day-one ROE-accretive. In fact, the bank itself warns that immediately after closing there may be a temporary decline in ROE until the released surplus capital is either reinvested in the business or distributed.
What Gets Released at Closing, and What Still Sits Behind Conditions
Anyone reading the CAL sale as NIS 2.873 billion of fresh, immediate capital is reading it too aggressively. There is a cash layer, an accounting-gain layer, and a contingent-value layer here, and they do not behave the same way.
| Layer | Disclosed amount | When it arrives | What can still move |
|---|---|---|---|
| Immediate consideration | About NIS 2.694 billion | At closing | Subject to adjustments, including for dividends and certain expenses |
| Contingent consideration | Up to about NIS 180 million | Across 2027 and 2028 | Depends on a performance threshold tied to CAL |
| Estimated immediate after-tax gain | About NIS 370 million | At closing, in December 31, 2025 terms | Shrinks as CAL's carrying value grows before closing |
| Possible future after-tax gain | Up to about NIS 125 million | Only if the contingent piece is earned | Not part of the transaction's day-one economics |
That distinction matters. The immediate consideration is the cash layer. The NIS 370 million is the accounting-capital layer the bank expects to recognize against CAL's carrying value. And the up to NIS 180 million, from which the additional up to NIS 125 million after tax may be derived, is later upside rather than closing-day capital.
There is one more detail with economic weight. The immediate consideration is supposed to start accruing interest, at the agreed rate, six months after signing and until closing. A delay therefore does not leave the transaction frozen in time. The numbers move with the calendar.
Timing Is Part of the Thesis
On March 10, 2026, Discount disclosed that a notice had been sent to the buyers one day earlier extending the outside closing date by 30 days, to April 19, 2026. The same filing added that beyond this extension the parties may extend the agreement by another three and a half months, and that in certain circumstances the bank may extend it by an additional 90 days. If all those extensions were exercised, the long-stop date would move to November 1, 2026.
| Milestone | Date | Why it matters |
|---|---|---|
| Sale agreement signed | September 19, 2025 | This is when the immediate consideration, contingent consideration, and closing conditions were set |
| First disclosed extension | March 10, 2026 | Pushes the outside date to April 19, 2026 |
| Current outside date | April 19, 2026 | This is no longer an immediate early-2026 closing story |
| Possible final outside date if all extensions are used | November 1, 2026 | Makes the capital release something that could slip deep into 2026 |
| Contingent-consideration performance years | 2027 and 2028 | Part of the value arrives only after the deal itself closes |
The delay changes more than the date. On one side, the immediate consideration starts accruing interest six months after signing. On the other, as long as closing has not happened, Discount keeps recognizing its share of CAL's profits, so CAL's balance-sheet carrying value rises and the sale-gain estimate falls. Delay does not erase value, but it does shift value across three buckets: pre-close CAL earnings, sale gain at closing, and the moment the released capital can actually be redeployed.
That is why CAL still sits on the Discount thesis as an overhang. Until the sale closes, it is hard to talk about surplus capital as if it is already working inside the balance sheet.
Where the Capital Release Is Cleanest, In Regulatory Capital
This is where the disclosure becomes much cleaner. Discount says that once the transaction closes, CAL's risk-weighted assets will no longer be included in the group's risk-weighted assets, implying a net decline of about NIS 17.387 billion in RWA, in December 31, 2025 terms. The bank also stresses that this figure does not include the operational-risk benefit, because that release is spread over three years.
In plain terms, the regulatory-capital release is real. It is just not the same thing as the NIS 2.873 billion headline.
As of December 31, 2025, Discount's Common Equity Tier 1 ratio stood at 10.38%, against a required minimum of 9.20%. The bank estimates that the RWA reduction and other transaction effects would raise the CET1 ratio by 0.44% if the full gain on the CAL sale were distributed as a dividend, and by 0.55% if it were not distributed. In end-2025 terms, that would put CET1 in a range of about 10.82% to 10.93%.
The right way to read that chart is through capital headroom, not through the ratio headline alone. Before the sale, Discount had 1.18 percentage points of buffer above the minimum. After the sale, that rises to about 1.62 to 1.73 percentage points. That is a meaningful improvement. It also explains why the CAL sale matters more as a flexibility story than as an immediate earnings story.
Still, this should not be overstated. Even after that uplift, Discount does not suddenly become a bank swimming in extreme excess capital. This is a meaningful release that widens strategic room, supports loan growth or distributions, and reduces constraint. It still requires disciplined capital deployment.
Why ROE Can Fall Before It Improves
This is the part the market can easily miss on first read. Intuitively, selling a capital-heavy asset and releasing capital sounds supportive for ROE. Discount says the opposite for the immediate post-close period: ROE may decline temporarily because it takes time to invest the full surplus capital back into the bank's businesses or distribute it.
The economic logic is simple. On closing day, the bank loses CAL's ongoing earnings contribution, but gets back capital that has not yet been redeployed. The denominator expands before the numerator is fully rebuilt. That means the deal first improves flexibility, and only later, if management allocates the released capital well, can it improve returns.
That point matters even more because Discount closed 2025 with reported ROE of 12.6%, or 13.7% after neutralizing certain items, while the Discount 2030 targets call for ROE of at least 13% to 14%. In other words, the bank was not sitting on an exceptionally high ROE even before the sale. If the gap between closing and capital redeployment stretches out, ROE can look weaker before it looks stronger.
The key sentence for the next phase is therefore straightforward: the CAL sale is a capital deal before it is an earnings deal. It opens room to act, but it does not remove the need to prove that the core bank can earn attractive returns on the post-sale capital base.
Why the January Rating Updates Matter in This Context
The two January 2026 rating updates, from Midroog and S&P Maalot, kept stable outlooks in place while at the same time widening the issuance frameworks. Midroog raised the senior-debt framework to up to NIS 2.65 billion from NIS 750 million, the CoCo framework to NIS 620 million from NIS 450 million, and the commercial-paper framework to NIS 1.35 billion from NIS 1.0 billion. The Maalot update confirmed the same ceilings.
That does not make CAL less important. If anything, it says the bank is not managing the balance sheet around one single event. It is keeping both capital-markets flexibility and CAL-sale flexibility open at the same time. That reinforces the more conservative reading: the CAL release is real, but it still needs to sit inside a broader framework of funding access, loan growth, and capital allocation.
Bottom Line
How much capital really gets released? At the cash layer, day one looks like about NIS 2.694 billion, not NIS 2.873 billion. At the accounting layer, Discount is talking about NIS 370 million after tax in end-2025 terms, with additional upside of up to about NIS 125 million only if the contingent consideration is earned. At the regulatory layer, this is a story of about NIS 17.387 billion of net RWA release and 44 to 55 basis points of CET1 uplift.
When does it get released? Not necessarily in April, and under the full extension path possibly not until November 1, 2026. Anyone reading 2026 as if all the CAL value is already closed and already redeployed through the balance sheet is moving too fast.
And what does it do to ROE? In the near term, probably exactly what the bank already warned about: temporary dilution. The real test comes after that, and it is not whether Discount managed to sell CAL. It is whether Discount can turn the released capital back into durable banking returns.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.